Skip to main content
Top
Published in: Hepatology International 3/2018

Open Access 01-05-2018 | Review Article

Beyond KCH selection and options in acute liver failure

Authors: William Bernal, Roger Williams

Published in: Hepatology International | Issue 3/2018

Login to get access

Abstract

The King’s prognostic criteria for patients with acute liver failure (ALF) introduced in 1989 have been used worldwide. This distinguished for the first time cases with ‘hyper-acute’ course (characteristically paracetamol overdose) where there is a better chance of recovery with medical supportive care alone from those etiologies with a less acute course and paradoxically lower chances of ‘spontaneous’ recovery. Ongoing use showed the limited sensitivity of the criteria to constitute a significant practical limitation. Subsequent models including the MELD score and composite ones with markers of necrosis, an apoptotic liver cell death, proposed to improve sensitivity did not have the required high specificity. Two recent models utilizing new availability of web- and app-based computing delivering outcome predication through sophisticated algorithms are described. The first is a dynamic model described for paracetamol-induced ALF based upon admission findings and sequential variables over the first 2 days. The new model of the US Acute Liver Failure group was devised to cover all etiologies of ALF for predicting ‘transplant-free’ survival and accurately predicated spontaneous survival in two-thirds of cases. Improved survival results with medical management, particularly in hyper-acute cases, now approach those obtained with successful liver transplant and have raised the question of transplant benefit. Also considered in the review are new non-transplant approaches to treatment including the use of plasma exchange and based on successful results in acute-on-chronic liver failure, agents to modulate and improve hepatic regeneration.
Literature
1.
go back to reference Gazzard BG, Widdop B, Davis M, Hughes RD, Goulding R, Williams R. Early prediction of the outcome of a paracetamol overdose based on an analysis of 163 patients. Postgrad Med J 1977;53(619):243–247.CrossRefPubMedPubMedCentral Gazzard BG, Widdop B, Davis M, Hughes RD, Goulding R, Williams R. Early prediction of the outcome of a paracetamol overdose based on an analysis of 163 patients. Postgrad Med J 1977;53(619):243–247.CrossRefPubMedPubMedCentral
2.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97(2):439–445.CrossRefPubMed O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97(2):439–445.CrossRefPubMed
3.
go back to reference O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342(8866):273–275.CrossRefPubMed O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342(8866):273–275.CrossRefPubMed
4.
go back to reference Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013;59(1):74–80.CrossRefPubMed Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013;59(1):74–80.CrossRefPubMed
5.
go back to reference Slack A, Auzinger G, Willars C, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014;34(1):42–48.CrossRefPubMed Slack A, Auzinger G, Willars C, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014;34(1):42–48.CrossRefPubMed
6.
go back to reference Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology 2017;31:31. Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology 2017;31:31.
7.
go back to reference O’Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol 2014;60(3):663–670.CrossRefPubMed O’Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol 2014;60(3):663–670.CrossRefPubMed
8.
go back to reference Donnelly MC, Davidson JS, Martin K, Baird A, Hayes PC, Simpson KJ. Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study). Aliment Pharmacol Ther 2017;45(6):833–843.CrossRefPubMed Donnelly MC, Davidson JS, Martin K, Baird A, Hayes PC, Simpson KJ. Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study). Aliment Pharmacol Ther 2017;45(6):833–843.CrossRefPubMed
9.
go back to reference Reuben A, Tillman H, Fontana R, et al. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: an observational cohort study. Ann Intern Med 2016;164(11):724–732.CrossRefPubMedPubMedCentral Reuben A, Tillman H, Fontana R, et al. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: an observational cohort study. Ann Intern Med 2016;164(11):724–732.CrossRefPubMedPubMedCentral
10.
go back to reference Oketani M, Ido A, Nakayama N, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 2013;43(2):97–105.CrossRefPubMed Oketani M, Ido A, Nakayama N, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 2013;43(2):97–105.CrossRefPubMed
11.
go back to reference Ichai P, Legeai C, Francoz C, et al. Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl 2015;21(4):512–523.CrossRefPubMed Ichai P, Legeai C, Francoz C, et al. Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl 2015;21(4):512–523.CrossRefPubMed
12.
go back to reference Simpson KJ, Bates CM, Henderson NC, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 2009;15(6):600–609.CrossRefPubMed Simpson KJ, Bates CM, Henderson NC, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 2009;15(6):600–609.CrossRefPubMed
13.
go back to reference Bernal W, Cross TJS, Auzinger G, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol 2009;50(2):306–313.CrossRefPubMed Bernal W, Cross TJS, Auzinger G, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol 2009;50(2):306–313.CrossRefPubMed
14.
go back to reference Brandsaeter B, Hockerstedt K, Friman S, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transpl 2002;8(11):1055–1062.CrossRefPubMed Brandsaeter B, Hockerstedt K, Friman S, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transpl 2002;8(11):1055–1062.CrossRefPubMed
15.
go back to reference Reddy KR, Ellerbe C, Schilsky M, et al. Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl 2016;22(4):505–515.CrossRefPubMedPubMedCentral Reddy KR, Ellerbe C, Schilsky M, et al. Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl 2016;22(4):505–515.CrossRefPubMedPubMedCentral
16.
go back to reference Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002;359(9306):558–563.CrossRefPubMed Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002;359(9306):558–563.CrossRefPubMed
17.
go back to reference Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006;34(2):337–343.CrossRefPubMed Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006;34(2):337–343.CrossRefPubMed
18.
go back to reference Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11(9):1073–1079.CrossRefPubMed Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11(9):1073–1079.CrossRefPubMed
19.
go back to reference Cholongitas E, O’Beirne J, Betrossian A, et al. Prognostic impact of lactate in acute liver failure. Liver Transpl 2008;14(1):121–122 (author reply 3).CrossRefPubMed Cholongitas E, O’Beirne J, Betrossian A, et al. Prognostic impact of lactate in acute liver failure. Liver Transpl 2008;14(1):121–122 (author reply 3).CrossRefPubMed
20.
go back to reference Craig DGN, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010;31(10):1064–1076.PubMed Craig DGN, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010;31(10):1064–1076.PubMed
21.
go back to reference McPhail MJW, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol 2010;53(3):492–499.CrossRefPubMed McPhail MJW, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol 2010;53(3):492–499.CrossRefPubMed
22.
go back to reference McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King’s College Criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol 2016;14(4):516–525.e5 (quiz e43–e45).CrossRefPubMed McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King’s College Criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol 2016;14(4):516–525.e5 (quiz e43–e45).CrossRefPubMed
23.
go back to reference Kumar R, Shalimar Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 2012;61(7):1068–1075.CrossRefPubMed Kumar R, Shalimar Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut 2012;61(7):1068–1075.CrossRefPubMed
24.
go back to reference Bernal W, Wang Y, Maggs J, et al. Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study. Lancet Gastroenterol Hepatol 2016;1(3):217–225.CrossRefPubMed Bernal W, Wang Y, Maggs J, et al. Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study. Lancet Gastroenterol Hepatol 2016;1(3):217–225.CrossRefPubMed
25.
go back to reference Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a model to predict transplant-free survival of patients with acute liver failure. Clin Gastroenterol Hepatol 2016;14(8):1199–1206.e2.CrossRefPubMedPubMedCentral Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a model to predict transplant-free survival of patients with acute liver failure. Clin Gastroenterol Hepatol 2016;14(8):1199–1206.e2.CrossRefPubMedPubMedCentral
26.
go back to reference Craig DG, Zafar S, Reid TW, et al. The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2012;35(12):1408–1415.CrossRefPubMed Craig DG, Zafar S, Reid TW, et al. The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2012;35(12):1408–1415.CrossRefPubMed
27.
go back to reference Cholongitas E, Theocharidou E, Vasianopoulou P, et al. Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl 2012;18(4):405–412.CrossRefPubMed Cholongitas E, Theocharidou E, Vasianopoulou P, et al. Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl 2012;18(4):405–412.CrossRefPubMed
28.
go back to reference Schmidt L, Larsen F. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007;45:789–796.CrossRefPubMed Schmidt L, Larsen F. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007;45:789–796.CrossRefPubMed
29.
go back to reference Craig DGN, Reid TWDJ, Wright EC, et al. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2012;35(6):705–713.CrossRefPubMed Craig DGN, Reid TWDJ, Wright EC, et al. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2012;35(6):705–713.CrossRefPubMed
30.
31.
go back to reference Bechmann LP, Jochum C, Kocabayoglu P, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 2010;53(4):639–647.CrossRefPubMed Bechmann LP, Jochum C, Kocabayoglu P, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 2010;53(4):639–647.CrossRefPubMed
32.
go back to reference Rutherford A, King LY, Hynan LS, et al. Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 2012;143(5):1237–1243.CrossRefPubMed Rutherford A, King LY, Hynan LS, et al. Development of an accurate index for predicting outcomes of patients with acute liver failure. Gastroenterology 2012;143(5):1237–1243.CrossRefPubMed
33.
go back to reference Craig DG, Simpson KJ. Accuracy of the ALFSG index as a triage marker in acute liver failure. Gastroenterology 2013;144(1):e25.CrossRefPubMed Craig DG, Simpson KJ. Accuracy of the ALFSG index as a triage marker in acute liver failure. Gastroenterology 2013;144(1):e25.CrossRefPubMed
34.
go back to reference Antoine DJ, Jenkins RE, Dear JW, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012;56(5):1070–1079.CrossRefPubMedPubMedCentral Antoine DJ, Jenkins RE, Dear JW, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012;56(5):1070–1079.CrossRefPubMedPubMedCentral
35.
go back to reference Craig DGN, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 2011;31(8):1127–1136.CrossRefPubMed Craig DGN, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 2011;31(8):1127–1136.CrossRefPubMed
36.
go back to reference Dear JW, Clarke JI, Francis B, et al. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol Hepatol 2018;3(2):104–113.CrossRefPubMed Dear JW, Clarke JI, Francis B, et al. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol Hepatol 2018;3(2):104–113.CrossRefPubMed
37.
go back to reference Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013;58(2):777–787.CrossRefPubMed Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013;58(2):777–787.CrossRefPubMed
38.
go back to reference Stravitz RT, Ellerbe C, Durkalski V, et al. Thrombocytopenia Is associated with multi-organ system failure in patients with acute liver failure. Clin Gastroenterol Hepatol 2016;14(4):613–620.CrossRefPubMed Stravitz RT, Ellerbe C, Durkalski V, et al. Thrombocytopenia Is associated with multi-organ system failure in patients with acute liver failure. Clin Gastroenterol Hepatol 2016;14(4):613–620.CrossRefPubMed
39.
go back to reference Shakil AO, Jones BC, Lee RG, Federle MP, Fung JJ, Rakela J. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 2000;45(2):334–339.CrossRefPubMed Shakil AO, Jones BC, Lee RG, Federle MP, Fung JJ, Rakela J. Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 2000;45(2):334–339.CrossRefPubMed
40.
go back to reference Zabron A, Quaglia A, Peddu P, et al. Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure. Liver Int 2018 (In Press). Zabron A, Quaglia A, Peddu P, et al. Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure. Liver Int 2018 (In Press).
41.
go back to reference Yamagishi Y, Saito H, Tada S, et al. Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol 2005;20(12):1843–1849.CrossRefPubMed Yamagishi Y, Saito H, Tada S, et al. Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol 2005;20(12):1843–1849.CrossRefPubMed
44.
go back to reference Germani G, Theocharidou E, Adam R, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol 2012;57(2):288–296.CrossRefPubMed Germani G, Theocharidou E, Adam R, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol 2012;57(2):288–296.CrossRefPubMed
45.
go back to reference Yamashiki N, Sugawara Y, Tamura S, et al. Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey. Liver Transpl 2012;18(9):1069–1077.CrossRefPubMed Yamashiki N, Sugawara Y, Tamura S, et al. Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey. Liver Transpl 2012;18(9):1069–1077.CrossRefPubMed
46.
go back to reference Goldaracena N, Spetzler VN, Marquez M, et al. Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failure. Am J Transplant 2015;15(6):1591–1597.CrossRefPubMed Goldaracena N, Spetzler VN, Marquez M, et al. Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failure. Am J Transplant 2015;15(6):1591–1597.CrossRefPubMed
47.
go back to reference Karvellas CJ, Safinia N, Auzinger G, et al. Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study. Liver Int 2010;30(6):826–833.CrossRefPubMed Karvellas CJ, Safinia N, Auzinger G, et al. Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study. Liver Int 2010;30(6):826–833.CrossRefPubMed
48.
go back to reference Craig DGN, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 2012;73(2):285–294.CrossRefPubMedPubMedCentral Craig DGN, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 2012;73(2):285–294.CrossRefPubMedPubMedCentral
49.
go back to reference Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013;159(8):522–531.CrossRefPubMed Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013;159(8):522–531.CrossRefPubMed
50.
go back to reference Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016;64(1):69–78.CrossRefPubMed Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016;64(1):69–78.CrossRefPubMed
51.
go back to reference European Association for the Study of the Liver. Electronic address eee, Clinical practice guidelines p, Wendon J, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66(5):1047–1081.CrossRef European Association for the Study of the Liver. Electronic address eee, Clinical practice guidelines p, Wendon J, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66(5):1047–1081.CrossRef
52.
go back to reference Iansante V, Mitry RR, Filippi C, Fitzpatrick E, Dhawan A. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res 2017;06:06. Iansante V, Mitry RR, Filippi C, Fitzpatrick E, Dhawan A. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res 2017;06:06.
53.
go back to reference Ibars EP, Cortes M, Tolosa L, et al. Hepatocyte transplantation program: lessons learned and future strategies. World J Gastroenterol 2016;22(2):874–886.CrossRefPubMedPubMedCentral Ibars EP, Cortes M, Tolosa L, et al. Hepatocyte transplantation program: lessons learned and future strategies. World J Gastroenterol 2016;22(2):874–886.CrossRefPubMedPubMedCentral
54.
go back to reference Lin BL, Chen JF, Qiu WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology 2017;66(1):209–219.CrossRefPubMed Lin BL, Chen JF, Qiu WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology 2017;66(1):209–219.CrossRefPubMed
55.
go back to reference Kedarisetty CK, Anand L, Bhardwaj A, et al. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology 2015;148(7):1362–1370 (e7).CrossRefPubMed Kedarisetty CK, Anand L, Bhardwaj A, et al. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology 2015;148(7):1362–1370 (e7).CrossRefPubMed
56.
go back to reference Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6(2):97–106.CrossRefPubMed Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6(2):97–106.CrossRefPubMed
57.
go back to reference Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res 2008;38(10):970–979.CrossRefPubMed Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res 2008;38(10):970–979.CrossRefPubMed
Metadata
Title
Beyond KCH selection and options in acute liver failure
Authors
William Bernal
Roger Williams
Publication date
01-05-2018
Publisher
Springer India
Published in
Hepatology International / Issue 3/2018
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-018-9869-7

Other articles of this Issue 3/2018

Hepatology International 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.